MediBeacon receives regulatory approval to sell the Transdermal GFR System in China
MediBeacon(R) Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function The TGFR will be available for sale in China before the end of the year ST. LOUIS, Oct. 21, 2025 (GLOBE NEWSWIRE) — MediBeacon Inc., a medical technology company specializing […]